Association of T-helper cell cytokine level with age in patients with biliary atresia: a preliminary study

World J Pediatr. 2018 Aug;14(4):404-409. doi: 10.1007/s12519-018-0183-1. Epub 2018 Aug 29.

Abstract

Background: The pathogenesis of biliary atresia (BA) is associated with an inflammatory process involving the biliary tree. This study aimed to investigate the association of T-helper cell cytokine levels with age in patients with BA.

Methods: Twenty-eight patients with BA were divided into three groups according to their age (< 2 months, 2-3 months, and ≥ 3 months). All the patients underwent Kasai portoenterostomy. Blood samples were collected from the patients preoperatively, and the liver tissue specimens were obtained during surgery. We detected serum levels of interleukin (IL)-1β, IL-12p70, interferon (IFN)-γ, IL-6, IL-10, and transforming growth factor (TGF)-β1 and liver expression of IL-1β, IL-6, and TGF-β1.

Results: The serum levels of IL-1β, IL-12p70, IL-6, and IL-10 in patients aged ≥ 3 months were significantly higher than those in patients aged < 2 months. There were no significant age-related differences in the IL-1β, IL-6 and TGF-β1 expression levels in the liver tissue of patients with BA.

Conclusions: The serum levels of IL-1β, IL-6, IL-10 and IL-12p70 showed significant age-related differences in patients with BA. Interpretation of the role of cytokines in BA needs to take patient's age into consideration.

Keywords: Biliary atresia; Cytokines; Pathogenesis; T-helper cell.

Publication types

  • Comparative Study

MeSH terms

  • Age Factors
  • Analysis of Variance
  • Biliary Atresia / blood*
  • Biliary Atresia / physiopathology*
  • Biliary Atresia / surgery
  • Biomarkers / metabolism
  • China
  • Cohort Studies
  • Cytokines / metabolism*
  • Disease Progression
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Hospitals, University
  • Humans
  • Immunohistochemistry
  • Infant
  • Male
  • Portoenterostomy, Hepatic / methods*
  • Retrospective Studies
  • Risk Assessment
  • T-Lymphocytes, Helper-Inducer / metabolism*
  • Treatment Outcome

Substances

  • Biomarkers
  • Cytokines